Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of NOXA1 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | increases expression | ISO | Noxa1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of NOXA1 mRNA | CTD | PMID:22206623 | 17beta-estradiol | decreases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of NOXA1 mRNA | CTD | PMID:23019147 and PMID:31614463 | 17beta-estradiol | multiple interactions | ISO | NOXA1 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of NOXA1 mRNA | CTD | PMID:30165855 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of NOXA1 mRNA | CTD | PMID:26496021 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 6-dinitrotoluene affects the expression of NOXA1 mRNA | CTD | PMID:21346803 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | NOXA1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOXA1 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Noxa1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of NOXA1 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Noxa1 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of NOXA1 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Noxa1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of NOXA1 gene | CTD | PMID:31683443 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NOXA1 mRNA | CTD | PMID:30047161 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of NOXA1 mRNA | CTD | PMID:30047161 | apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NOXA1 mRNA] | CTD | PMID:24080574 | arsenite(3-) | decreases methylation | ISO | NOXA1 (Homo sapiens) | 6480464 | arsenite results in decreased methylation of NOXA1 promoter | CTD | PMID:23974009 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of NOXA1 mRNA | CTD | PMID:26496021 | bisphenol A | multiple interactions | ISO | NOXA1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOXA1 mRNA | CTD | PMID:28628672 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NOXA1 mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NOXA1 mRNA | CTD | PMID:25181051 | carbon nanotube | decreases expression | ISO | Noxa1 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of NOXA1 mRNA | CTD | PMID:25554681 | choline | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NOXA1 mRNA | CTD | PMID:20938992 | chrysene | decreases expression | ISO | Noxa1 (Mus musculus) | 6480464 | chrysene results in decreased expression of NOXA1 mRNA | CTD | PMID:26377693 | cisplatin | decreases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of NOXA1 mRNA | CTD | PMID:27392435 | decabromodiphenyl ether | affects expression | ISO | NOXA1 (Homo sapiens) | 6480464 | decabromobiphenyl ether affects the expression of NOXA1 mRNA | CTD | PMID:24834073 | dexamethasone | multiple interactions | ISO | NOXA1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOXA1 mRNA | CTD | PMID:28628672 | dioxygen | multiple interactions | EXP | | 6480464 | [Semaxinib co-treated with Oxygen deficiency] results in decreased expression of NOXA1 mRNA | CTD | PMID:24947524 | ethanol | increases expression | ISO | Noxa1 (Mus musculus) | 6480464 | Ethanol results in increased expression of NOXA1 mRNA | CTD | PMID:20026259 | folic acid | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NOXA1 mRNA more ... | CTD | PMID:20938992 and PMID:22206623 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of NOXA1 mRNA | CTD | PMID:27387713 | hexadecanoic acid | increases expression | EXP | | 6480464 | Palmitic Acid results in increased expression of NOXA1 mRNA | CTD | PMID:24080574 | hexadecanoic acid | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Palmitic Acid results in increased expression of NOXA1 mRNA] and U 0126 inhibits the reaction [Palmitic Acid results in increased expression of NOXA1 mRNA] | CTD | PMID:24080574 | indometacin | multiple interactions | ISO | NOXA1 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of NOXA1 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of NOXA1 mRNA | CTD | PMID:20938992 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of NOXA1 mRNA | CTD | PMID:30047161 | N-methyl-4-phenylpyridinium | increases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NOXA1 mRNA | CTD | PMID:24810058 | ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of NOXA1 mRNA | CTD | PMID:23358140 | ozone | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of NOXA1 mRNA | CTD | PMID:34911549 | paracetamol | decreases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of NOXA1 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of NOXA1 mRNA | CTD | PMID:33387578 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of NOXA1 mRNA | CTD | PMID:32680482 | progesterone | decreases expression | ISO | Noxa1 (Mus musculus) | 6480464 | Progesterone results in decreased expression of NOXA1 mRNA | CTD | PMID:22238285 | rotenone | increases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Rotenone results in increased expression of NOXA1 mRNA | CTD | PMID:24810058 | silicon dioxide | decreases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of NOXA1 mRNA | CTD | PMID:25895662 | silicon dioxide | increases expression | ISO | Noxa1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of NOXA1 mRNA | CTD | PMID:29341224 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of NOXA1 mRNA | CTD | PMID:30047161 | sunitinib | increases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of NOXA1 mRNA | CTD | PMID:31533062 | testosterone | increases expression | ISO | Noxa1 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of NOXA1 mRNA | CTD | PMID:33848595 | testosterone | multiple interactions | ISO | Noxa1 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:33848595 | titanium dioxide | increases expression | ISO | Noxa1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NOXA1 mRNA | CTD | PMID:21259345 and PMID:23557971 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of NOXA1 mRNA | CTD | PMID:30012374 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of NOXA1 mRNA | CTD | PMID:33387578 | valproic acid | increases methylation | ISO | NOXA1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NOXA1 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | NOXA1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NOXA1 mRNA | CTD | PMID:29154799 | |